# Pharmacokinetics Study of Famitinib Malate Capsules in Healthy Subjects

> **NCT05046808** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 70 (actual)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** Famitinib Malate Capsules
- **DRUG:** Famitinib Malate Capsules
- **DRUG:** Famitinib Malate Capsules
- **DRUG:** Famitinib Malate Capsules
- **DRUG:** Famitinib Malate Capsules

## Key facts

- **NCT ID:** NCT05046808
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-23
- **Primary completion:** 2021-10-08
- **Final completion:** 2021-11-22
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2023-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05046808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05046808, "Pharmacokinetics Study of Famitinib Malate Capsules in Healthy Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05046808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*